Department of Neuroscience, The School of Translational Medicine, Monash University, Level 6 Alfred Centre, 99 Commercial Rd, Melbourne, VIC, 3004 VIC, Australia.
Alfred Health, Prahran, VIC, Australia.
J Neuroinflammation. 2024 May 8;21(1):122. doi: 10.1186/s12974-024-03093-9.
Pneumonia is a common comorbidity in patients with severe traumatic brain injury (TBI), and is associated with increased morbidity and mortality. In this study, we established a model of intratracheal Klebsiella pneumoniae administration in young adult male and female mice, at 4 days following an experimental TBI, to investigate how K. pneumoniae infection influences acute post-TBI outcomes. A dose-response curve determined the optimal dose of K. pneumoniae for inoculation (1 x 10^6 colony forming units), and administration at 4 days post-TBI resulted in transient body weight loss and sickness behaviors (hypoactivity and acute dyspnea). K. pneumoniae infection led to an increase in pro-inflammatory cytokines in serum and bronchoalveolar lavage fluid at 24 h post-infection, in both TBI and sham (uninjured) mice. By 7 days, when myeloperoxidase + neutrophil numbers had returned to baseline in all groups, lung histopathology was observed with an increase in airspace size in TBI + K. pneumoniae mice compared to TBI + vehicle mice. In the brain, increased neuroinflammatory gene expression was observed acutely in response to TBI, with an exacerbated increase in Ccl2 and Hmox1 in TBI + K. pneumoniae mice compared to either TBI or K. pneumoniae alone. However, the presence of neuroinflammatory immune cells in the injured brain, and the extent of damage to cortical and hippocampal brain tissue, was comparable between K. pneumoniae and vehicle-treated mice by 7 days. Examination of the fecal microbiome across a time course did not reveal any pronounced effects of either injury or K. pneumoniae on bacterial diversity or abundance. Together, these findings demonstrate that K. pneumoniae lung infection after TBI induces an acute and transient inflammatory response, primarily localized to the lungs with some systemic effects. However, this infection had minimal impact on secondary injury processes in the brain following TBI. Future studies are needed to evaluate the potential longer-term consequences of this dual-hit insult.
肺炎是严重创伤性脑损伤(TBI)患者的常见合并症,与发病率和死亡率增加有关。在这项研究中,我们在 TBI 后 4 天建立了年轻成年雄性和雌性小鼠经气管内肺炎克雷伯氏菌给药的模型,以研究肺炎克雷伯氏菌感染如何影响急性 TBI 后结局。剂量反应曲线确定了接种肺炎克雷伯氏菌的最佳剂量(1×10^6 集落形成单位),TBI 后 4 天给药导致短暂的体重减轻和疾病行为(活动减少和急性呼吸困难)。感染后 24 小时,TBI 和假手术(未受伤)小鼠的血清和支气管肺泡灌洗液中促炎细胞因子增加,肺炎克雷伯氏菌感染导致。到第 7 天,所有组的髓过氧化物酶+中性粒细胞数量已恢复到基线时,与 TBI+载体小鼠相比,TBI+肺炎克雷伯氏菌小鼠的肺组织病理学观察到肺泡空间增大。在大脑中,TBI 会导致神经炎症基因表达急性增加,与 TBI+肺炎克雷伯氏菌小鼠相比,TBI 或肺炎克雷伯氏菌单独处理的小鼠的 Ccl2 和 Hmox1 表达增加更为明显。然而,在受伤的大脑中存在神经炎症免疫细胞,以及皮质和海马脑组织的损伤程度,在第 7 天时,肺炎克雷伯氏菌和载体处理的小鼠之间无明显差异。在时间过程中对粪便微生物组的检查未发现任何明显的损伤或肺炎克雷伯氏菌对细菌多样性或丰度的影响。总之,这些发现表明,TBI 后肺炎克雷伯氏菌肺部感染会引起急性和短暂的炎症反应,主要局限于肺部,有一些全身影响。然而,这种感染对 TBI 后大脑的继发性损伤过程影响很小。需要进一步研究以评估这种双重打击的潜在长期后果。